Airway hyperreactivity is frequent in non-asthmatic children with sickle cell disease

Summary Background Asthma is associated with poorer outcomes in sickle cell disease (SCD). Whether AHR can exist in SCD as a distinct entity, separate and independent of asthma, is unknown. Aims Our goal was to elucidate the prevalence of AHR, as measured by a methacholine challenge test (MCT), in c...

Full description

Saved in:
Bibliographic Details
Published inPediatric pulmonology Vol. 51; no. 9; pp. 950 - 957
Main Authors Shilo, Natalie R., Alawadi, Aceel, Allard-Coutu, Alexandra, Robitaille, Nancy, Pastore, Yves, Bérubé, Denis, Jacob, Sheila V., Abish, Sharon, Dauletbaev, Nurlan, Lands, Larry C.
Format Journal Article
LanguageEnglish
Published United States Blackwell Publishing Ltd 01.09.2016
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Summary Background Asthma is associated with poorer outcomes in sickle cell disease (SCD). Whether AHR can exist in SCD as a distinct entity, separate and independent of asthma, is unknown. Aims Our goal was to elucidate the prevalence of AHR, as measured by a methacholine challenge test (MCT), in children with SCD who did not have concomitant asthma or any recent history of acute chest syndrome (ACS). To determine if AHR was associated with asthma‐like symptoms, we compared the results of the MCT to a validated asthma questionnaire. We also examined if a correlation between AHR and inflammatory markers exists. Methods AHR was identified with a positive MCT defined as a provocation concentration (PC20) < 4 mg/ml. The children and/or their parents completed the ISAAC (International Study of Asthma and Allergies in Children) questionnaire. We obtained blood, urine, and exhaled breath condensate samples. We measured cysteinyl leukotriene levels in urine and exhaled breath condensate via enzyme immunoassay. Results Twenty‐nine of forty children (72.5%) had a positive MCT. Nine (31.0%) also reported asthma‐like symptoms on questionnaire. Inflammatory markers did not correlate with AHR. Among MCT positive subjects, those on hydroxyurea had significantly less severe AHR as quantified by PC20 (P = 0.014). Conclusions In children with SCD, there is a high prevalence of AHR that is not associated with asthma‐like symptoms. AHR may be a distinct entity in children with SCD, existing in the absence of concomitant asthma. Hydroxyurea therapy might lessen the severity of AHR in affected individuals. Pediatr Pulmonol. 2016; 51:950–957. © 2015 Wiley Periodicals, Inc.
Bibliography:istex:50CD1A0E34427F9F3482B9E4F5DF764B870CF741
Division of Respiratory Medicine, The Montreal Children's Hospital
ark:/67375/WNG-C26FZ43K-W
ArticleID:PPUL23374
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:8755-6863
1099-0496
DOI:10.1002/ppul.23374